Literature DB >> 23857516

Gender identities and gender dysphoria in the Netherlands.

Lisette Kuyper1, Ciel Wijsen.   

Abstract

Several studies estimate the prevalence of gender dysphoria among adults by examining the number of individuals turning to health services. Since individuals might be hesitant to seek medical care related to gender dysphoria, these studies could underestimate the prevalence. The studies also lack information regarding the variance among different aspects of gender dysphoric conditions. Therefore, the current study estimated the prevalence by examining self-reported gender identity and dysphoria in a Dutch population sample (N = 8,064, aged 15-70 years old). Three measures assessed aspects of gender dysphoria: gender identity, dislike of the natal female/male body, and wish to obtain hormones/sex reassignment surgery. Results showed that 4.6 % of the natal men and 3.2 % of the natal women reported an ambivalent gender identity (equal identification with other sex as with sex assigned at birth) and 1.1 % of the natal men and 0.8 % of the natal women reported an incongruent gender identity (stronger identification with other sex as with sex assigned at birth). Lower percentages reported a dislike of their natal body and/or a wish for hormones/surgery. Combining these figures estimated the percentage of men reporting an ambivalent or incongruent gender identity combined with a dislike of their male body and a wish to obtain hormones/surgery at 0.6 %. For women, this was 0.2 %. These novel findings show that studies based on the number of individuals seeking medical care might underestimate the prevalence of gender dysphoria. Furthermore, the findings argue against a dichotomous approach to gender dysphoria.

Entities:  

Mesh:

Year:  2013        PMID: 23857516     DOI: 10.1007/s10508-013-0140-y

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  32 in total

Review 1.  To treat or not to treat: puberty suppression in childhood-onset gender dysphoria.

Authors:  Rosalia Costa; Polly Carmichael; Marco Colizzi
Journal:  Nat Rev Urol       Date:  2016-07-19       Impact factor: 14.432

2.  A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru.

Authors:  Michele Andrasik; Doug Grove; Gail Broder; Hyman Scott; Mary Allen; Shelly Karuna
Journal:  Vaccine       Date:  2019-06-05       Impact factor: 3.641

3.  Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples.

Authors:  Esther L Meerwijk; Jae M Sevelius
Journal:  Am J Public Health       Date:  2017-02       Impact factor: 9.308

4.  Brief Report: Gender Identity Differences in Autistic Adults: Associations with Perceptual and Socio-cognitive Profiles.

Authors:  Reubs J Walsh; Lydia Krabbendam; Jeroen Dewinter; Sander Begeer
Journal:  J Autism Dev Disord       Date:  2018-12

Review 5.  [Trans healthcare : Between depsychopathologization and a needs-based treatment of accompanying mental disorders].

Authors:  T O Nieder; A Güldenring; A Köhler; P Briken
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

6.  The Epidemiology of Gender Dysphoria in Iran: The First Nationwide Study.

Authors:  Ali Talaei; Arya Hedjazi; Nazilla Badieyan Moosavi; Maliheh Dadgarmoghaddam; Nasim Lotfinejad; Behzad S Khorashad
Journal:  Arch Sex Behav       Date:  2022-05-05

7.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

Review 8.  Prevalence of Transgender Depends on the "Case" Definition: A Systematic Review.

Authors:  Lindsay Collin; Sari L Reisner; Vin Tangpricha; Michael Goodman
Journal:  J Sex Med       Date:  2016-03-25       Impact factor: 3.802

Review 9.  Epidemiological considerations in transgender health: A systematic review with focus on higher quality data.

Authors:  Qi Zhang; Michael Goodman; Noah Adams; Trevor Corneil; Leila Hashemi; Baudewijntje Kreukels; Joz Motmans; Rachel Snyder; Eli Coleman
Journal:  Int J Transgend Health       Date:  2020-04-15

10.  Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists.

Authors:  Angela H E M Maas; Giuseppe Rosano; Renata Cifkova; Alaide Chieffo; Dorenda van Dijken; Haitham Hamoda; Vijay Kunadian; Ellen Laan; Irene Lambrinoudaki; Kate Maclaran; Nick Panay; John C Stevenson; Mick van Trotsenburg; Peter Collins
Journal:  Eur Heart J       Date:  2021-03-07       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.